Sanofi, Arrowhead, Novartis among winners of EU recommendations this week
Source: SeekingAlpha
2026-04-24 11:19:46 ET
More on Sanofi, Novartis, etc.
- Sanofi (SAN:CA) Q1 2026 Earnings Call Transcript
- Sanofi 2026 Q1 - Results - Earnings Call Presentation
- Novartis: Buy Thesis Fades Into Q1 2026 Results (Rating Downgrade)
- WHO prequalifies Novartis’ Coartem Baby for infants
- Sanofi beats Q1 estimates; reaffirms FY26 outlook
Read the full article on Seeking Alpha
For further details see:
Sanofi, Arrowhead, Novartis among winners of EU recommendations this week
Novartis AG
NASDAQ: NVS
NVS Trading
-0.26% G/L:
$150.47 Last:
852,043 Volume:
$151.84 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
